We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,584 hedge funds and large institutions have $251B invested in Johnson & Johnson in 2018 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 1,107 increasing their positions, 1,110 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 69

18% more funds holding in top 10

Funds holding in top 10: 553651 (+98)

14% more capital invested

Capital invested by funds: $219B → $251B (+$31.6B)

0.08% more ownership

Funds ownership: 67.58%67.66% (+0.08%)

0% less repeat investments, than reductions

Existing positions increased: 1,107 | Existing positions reduced: 1,110

0% less funds holding

Funds holding: 2,5932,584 (-9)

26% less call options, than puts

Call options by funds: $1.49B | Put options by funds: $2.02B

Holders
2,584
Holders Change
-9
Holders Change %
-0.35%
% of All Funds
59.06%
Holding in Top 10
651
Holding in Top 10 Change
+98
Holding in Top 10 Change %
+17.72%
% of All Funds
14.88%
New
84
Increased
1,107
Reduced
1,110
Closed
69
Calls
$1.49B
Puts
$2.02B
Net Calls
-$525M
Net Calls Change
-$83.1M
Name Holding Trade Value Shares
Change
Change in
Stake
GJIC
476
Gamble Jones Investment Counsel
California
$26.5M -$161K -1,210 -0.6%
CC
477
Cadinha & Co
Hawaii
$26.4M +$65K +489 +0.3%
BC
478
Blackhill Capital
New Jersey
$26.4M
CIM
479
Corda Investment Management
Texas
$26.3M -$469K -3,527 -2%
WP
480
WMS Partners
Maryland
$26.1M +$34.5K +260 +0.1%
CTC
481
Central Trust Company
Missouri
$25.9M +$40.5K +305 +0.2%
BGC
482
Beutel, Goodman & Co
Ontario, Canada
$25.7M -$510K -3,839 -2%
JIM
483
Jupiter Investment Management
United Kingdom
$25.5M -$108K -812 -0.4%
AIA
484
Avalon Investment & Advisory
Texas
$25.4M +$110K +826 +0.5%
Cohen & Steers
485
Cohen & Steers
New York
$25.4M +$16.5M +124,341 +208%
NP
486
NS Partners
United Kingdom
$25.4M +$125K +937 +0.5%
ISL
487
Ingalls & Snyder LLC
New York
$25.4M -$201K -1,509 -0.8%
BHWM
488
Bar Harbor Wealth Management
New Hampshire
$25.3M -$139K -1,043 -0.6%
PFM
489
Parsec Financial Management
North Carolina
$25.2M +$987K +7,428 +4%
SYBT
490
Stock Yards Bank & Trust
Kentucky
$25.2M +$3.71M +27,914 +18%
CIA
491
Capital Investment Advisors
Georgia
$25.1M +$370K +2,784 +2%
GI
492
GAMCO Investors
Connecticut
$25.1M -$147K -1,106 -0.6%
HJGA
493
Hardman Johnston Global Advisors
Connecticut
$25.1M -$122K -920 -0.5%
TCOV
494
Trust Company of Vermont
Vermont
$25.1M -$233K -1,754 -1%
ABC
495
Associated Banc-Corp
Wisconsin
$25.1M -$808K -6,081 -3%
MJRIC
496
Mogy Joel R Investment Counsel
California
$25M +$56.9K +428 +0.2%
CCM
497
Covington Capital Management
California
$24.9M -$132K -994 -0.5%
MTC
498
McDaniel Terry & Co
Texas
$24.8M -$106K -794 -0.4%
PIA
499
Piedmont Investment Advisors
North Carolina
$24.7M -$12.2M -92,064 -34%
HIMC
500
Heritage Investors Management Corp
Maryland
$24.7M -$124K -932 -0.5%

JNJ Hedge Fund Activity: Q3 2018 in Review

2,584 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2018, worth a combined $251B — up 14% from $219B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new JNJ positions and 69 closed out — a net gain of 15 holders — while 1,107 added to existing stakes and 1,110 trimmed.

The largest buyer was Capital International Investors, adding an estimated $2.49B. The largest seller was Capital World Investors, cutting an estimated $2.21B.

  • 2,584 institutional investors held Johnson & Johnson (JNJ) as of Q3 2018, down from 2,593 in Q2 2018.
  • Funds reported $251B of Johnson & Johnson stock for Q3 2018, up 14% quarter-over-quarter.
  • 84 funds opened new Johnson & Johnson positions in Q3 2018 and 69 closed out, a net change of +15 holders.
  • The largest Johnson & Johnson buyer in Q3 2018 was Capital International Investors, an estimated $2.49B added.
  • The largest Johnson & Johnson seller in Q3 2018 was Capital World Investors, an estimated $2.21B sold.

Based on aggregated 13F filings for Q3 2018.